FeesSafety
Pluang+

Northwest Bancshares reports Q3 net income of $51M, 31% loan growth, and declares $0.20 dividend per share.

Company Fundamentals
26 Oct 2026, 23:05 WIB
PRNewsWire
View Source
Bullish
Northwest Bancshares reports Q3 net income of $51M, 31% loan growth, and declares $0.20 dividend per share.

Northwest Bancshares posted a net income of $51 million for Q3 2026, a significant increase from $3 million a year earlier, driven by 31% growth in commercial and industrial loans and record revenue. The bank maintained strong credit quality with low charge-offs and declared a quarterly dividend of $0.20 per share, marking its 128th consecutive dividend payment. Despite a slight dip from the previous quarter, the company remains optimistic about continued growth, especially with new financial centers in Columbus and ongoing operational improvements.

Northwest Bancshares reported a third quarter 2026 GAAP net income of $51 million. For readers following the Financials sector, here is Pluang's market snapshot as of Oct 27, 2026 02:31 WIB: out of 142 priced US Financials stocks, 88 rose and 51 fell. Notable movers include GLXY at USD 15.50 with a 1-day change of +5.59%, AVAT at USD 1.17 with a 1-day change of -5.26%, and FIGR at USD 22.03 with a 1-day change of -5.00%.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
24 minutes ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
24 minutes ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
36 minutes ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
2 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App